title: ERK1/2 and AKT are vital factors in regulation of the migration of rat Schwann cells.
abstract: After peripheral nerve injury, Wallerian degeneration (WD) occurs in the distal nerve segment. During the process of degeneration, Schwann cells (SCs) dedifferentiate, proliferate and migrate to align in "bands of Büngner", providing structural guidance and growth-promoting substrates to regenerating axons. The molecular signals that trigger SCs migration remain unclear. Here, we explored the molecular characteristics of the migration of cultured SCs prepared from rat sciatic nerves that had degenerated. The results revealed that elevated p-ERK1/2 was coupled with the migration of SCs, activated either by nerve degeneration or the addition of placenta growth factor. However, the inhibition of ERK1/2 activity, which activated the PI3K pathway, did not show a significant negative effect on SC migratory potential. Combined inhibition of ERK1/2 and AKT activity resulted in a significant decrease in SCs motility. These molecular characteristics suggest that both the ERK1/2 and AKT signals are involved in the migratory potential of SCs. It may be helpful to understand the process of nerve regeneration and perspective on promoting peripheral nerve regeneration.
authors: Department of Hand Surgery, Central Hospital affiliated to Shenyang Medical College, Shenyang City, Liaoning Province, 110015, P.R. China.
authors: Hao
authors: H
authors: Yu
authors: Lili
authors: L
authors: Zhu
authors: Chongjie
authors: C
authors: Li
authors: Defeng
authors: D
authors: Sha
authors: Hai
authors: H
authors: Pan
authors: Ning
authors: N
authors: Wang
authors: Shuai
authors: S
authors: Ma
mesh_terms: D000818:Animals; D002070:Butadienes / Q000494:pharmacology; D002465:Cell Movement / Q000502:physiology*; D002867:Chromones / Q000494:pharmacology; D048049:Extracellular Signal-Regulated MAP Kinases / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D005786:Gene Expression Regulation; D009025:Morpholines / Q000494:pharmacology; D009570:Nitriles / Q000494:pharmacology; D010766:Phosphorylation; D051057:Proto-Oncogene Proteins c-akt / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012583:Schwann Cells / Q000502:physiology*; D015398:Signal Transduction / Q000502:physiology
chemical_list: D002070:Butadienes; D002867:Chromones; D009025:Morpholines; D009570:Nitriles; C113580:U 0126; C085911:2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one; D051057:Proto-Oncogene Proteins c-akt; D048049:Extracellular Signal-Regulated MAP Kinases
references: FASEB J. 2006 Jul;20(9):1495-7
references: 16754748
references: Cancer Cell. 2003 Jul;4(1):67-79
references: 12892714
references: Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):9267-71
references: 1924389
references: Genes Cells. 2014 Jan;19(1):66-77
references: 24256316
references: Eur J Neurosci. 2005 May;21(10):2611-23
references: 15926910
references: Mol Biol Cell. 2002 Jan;13(1):336-47
references: 11809843
references: Nat Neurosci. 2002 Sep;5(9):861-7
references: 12172551
references: J Clin Invest. 2006 May;116(5):1230-42
references: 16614757
references: Eur J Neurosci. 2000 Dec;12(12):4171-80
references: 11122329
references: J Pathol. 1999 Sep;189(1):66-71
references: 10451490
references: Neuron. 2012 Feb 23;73(4):729-42
references: 22365547
references: Nature. 2005 Dec 8;438(7069):820-7
references: 16341007
references: Brain Res. 1994 Aug 29;655(1-2):246-50
references: 7812780
references: Front Biol (Beijing). 2013 Aug 1;8(4):null
references: 24348522
references: Glia. 2011 Mar;59(3):379-96
references: 21264946
references: Eur J Neurosci. 1997 Jul;9(7):1450-60
references: 9240402
references: Gut. 2005 May;54(5):666-72
references: 15831913
references: J Cell Biol. 1987 Jun;104(6):1623-31
references: 3034917
references: Br J Cancer. 2010 Jun 29;103(1):82-9
references: 20551949
references: J Invest Dermatol. 2000 Dec;115(6):1000-7
references: 11121133
references: Leg Med (Tokyo). 2009 Mar;11(2):70-5
references: 18974019
references: Neuroreport. 2000 Jun 5;11(8):1651-4
references: 10852218
references: J Clin Invest. 1998 Mar 1;101(5):1055-63
references: 9486976